Trials / Conditions / Stage III Adrenal Cortex Carcinoma
Stage III Adrenal Cortex Carcinoma
3 registered clinical trials studyying Stage III Adrenal Cortex Carcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic NCT06006013 | Emory University | Phase 2 |
| Withdrawn | Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine NCT02831179 | Vanderbilt-Ingram Cancer Center | Phase 1 |
| Terminated | Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer NCT02720484 | Northwestern University | Phase 2 |